Immutep Limited (NASDAQ:IMMP – Get Free Report) shares passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $2.45 and traded as low as $2.40. Immutep shares last traded at $2.59, with a volume of 1,402,552 shares traded.
Immutep Price Performance
The stock’s 50 day moving average price is $2.45 and its 200 day moving average price is $2.23.
Institutional Investors Weigh In On Immutep
A hedge fund recently raised its stake in Immutep stock. Meridian Wealth Management LLC grew its position in Immutep Limited (NASDAQ:IMMP – Free Report) by 3.6% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 322,450 shares of the biotechnology company’s stock after purchasing an additional 11,250 shares during the quarter. Meridian Wealth Management LLC owned approximately 0.37% of Immutep worth $774,000 as of its most recent filing with the SEC. 2.32% of the stock is currently owned by institutional investors.
About Immutep
Immutep Limited, a clinical-stage biotechnology company, engages in developing novel LAG-3 Immunotherapy for cancer and autoimmune diseases. The company is involved in advancing therapeutics related to Lymphocyte Activation Gene-3 (LAG-3), a cell surface molecule that plays a vital role in regulating the immune system.
Featured Stories
- Five stocks we like better than Immutep
- What is a Bond Market Holiday? How to Invest and Trade
- High-Yield Texas Instruments Could Hit New Highs Soon
- What is a buyback in stocks? A comprehensive guide for investors
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- What Are the U.K. Market Holidays? How to Invest and Trade
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Immutep Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Immutep and related companies with MarketBeat.com's FREE daily email newsletter.
